Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: Results of a drug screening study

AIDS

Volumn 11, Issue 13, 1997, Pages 1603-1610

  Molina, Jean Michel ^a,e   Goguel, Jérome ^a   Sarfati, Claudine ^a   Chastang, Claude ^a   Desportes Livage, Isabelle ^a   Michiels, Jean François ^b   Maslo, Caroline ^a   Katlama, Christine ^a   Cotte, Laurent ^c   Leport, Catherine ^a   Raffi, François ^d   Derouin, Francis ^a   Modaï, Jacques ^a  

^a Hopitaux de Paris   (France)

^b Hôtel Dieu de Nice   (France)

^c HÔTEL DIEU   (France)

^d HÔTEL DIEU   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

Albendazole; Atovaquone; Enterocytozoon bieneusi; Fumagillin; HIV; Intestinal microsporidiosis; Metronidazole; Paromomycin; Thrombocytopenia; Treatment

Indexed keywords

ALBENDAZOLE; ATOVAQUONE; CHLOROQUINE; DOXYCYCLINE; FLUBENDAZOLE; FOLINIC ACID; FUMAGILLIN; ITRACONAZOLE; METRONIDAZOLE; NIFUROXAZIDE; PAROMOMYCIN; PYRIMETHAMINE; SPARFLOXACIN; SULFADIAZINE;

ABDOMINAL CRAMP; ANEMIA; ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG PURIFICATION; DRUG SAFETY; DRUG SCREENING; EPISTAXIS; FECES ANALYSIS; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROSPORIDIOSIS; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTOZOON; PURPURA; RASH; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL; VOMITING;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIPROTOZOAL AGENTS; CYCLOHEXANES; DIARRHEA; DRUG EVALUATION, PRECLINICAL; FATTY ACIDS, UNSATURATED; HUMANS; INTESTINAL DISEASES, PARASITIC; MALE; MICROSPORIDA; MICROSPORIDIOSIS; MULTICENTER STUDIES; PROSPECTIVE STUDIES; SESQUITERPENES; TREATMENT OUTCOME;

EID: 9844230956     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199713000-00009     Document Type: Article

References (33)

1. Eeftinck Schattenkerk JKM, Van Gool T, Van Ketel RI, et al.: Clinical significance of small-intestinal microsporidiosis in HIV-1 infected individuals. Lancet 1991, 337:895-898.
2. Molina JM, Sarfati C, Beauvais B, et al.: Intestinal microsporidiosis in HIV-infected patients with chronic unexplained diarrhea: prevalence, clinical and biological features. J Infect Dis 1993, 167:217-221.
3. Orenstein JM, Chiang J, Steinberg W, et al.: Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus infected patients. A report of 20 cases. Hum Pathol 1990, 21:475-481.
4. Pol S, Romana CA, Richard S, et al.: Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med 1993, 328:95-99.
5. Desportes I, Le Charpentier Y, Galian A, et al.: Occurence of a new microsporidian: Enterocytozoon bieneusi n.g., n.sp., in the enterocytes of a human patient with AIDS. J Protozool 1985, 32:250-254.
6. Cali A, Kotler DP, Orenstein JM: Septata intestinalis n.g., n.sp., an intestinal microsporidian associated with chronic diarrhea and dissemination in AIDS patients. J Euk Microbiol 1993, 40:101-112.
7. Hartskeerl RA, Van Gool T, Schuitema ARJ, Didier ES, Terpstra WJ: Genetic and immunological characterization of the microsporidian Septata intestinalis Cali, Kotler and Orenstein: reclassification to Encephalitozoon intestinalis. Parasitology 1995, 110:277-285.
8. Weber R, Bryan RT, Owen RL, Poles MA, Orenstein JM: Improved light-microscopical detection of microsporidia spores in stools and duodenal aspirates. N Engl J Med 1991, 326:161-166.
9. Van Gool T, Snijders F, Reiss P, et al.: Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. J Clin Pathol 1993, 46:694-699.
10. Beauvais B, Sarfati C, Molina JM, et al.: Comparative evaluation of five diagnostic methods for demonstration of microsporidia in stools and intestinal biopsy specimen. Ann Trop Med Parasitol 1993, 87:99-102.
11. David F, Schuitema ARJ, Sarfati C, et al.: Species identification of intestinal microsporidia by PCR in duodenal biopsies from HIV-infected patients. J Infect Dis 1996, 174:874-877.
12. Visvesvara G, Leitch G, Pieniazek N, et al.: Short term in vitro culture and molecular analysis of the microsporidian Enterocytozoon bieneusi. J Euk Microbiol 1995, 42:506-510.
13. Beauvais B, Sarfati C, Challier S, Derouin F: An in vitro model to assess the effect of antimicrobial agents on Encephalitozoon cuniculi. Antimicrob Agents Chemother 1994, 38:2440-2448.
14. Dieterich DT, Lew EA, Kotler DP, et al.: Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J Infect Dis 1994, 169:178-183.
15. Blanshard C, Ellis DS, Tovey DG, Dowell S, Gazzard BG: Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS 1992, 6:311-313.
16. Hing MC, Marriott DJ, Verre J, Field AS: Enteric microsporidiosis: response to azithromycin therapy. AIDS 1993, 7 (suppl 3):S45-S46.
17. Anwar-Bruni DM, Hogan SE, Schwartz DA, Wilcox CM, Bryan RT, Lennox JL: Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1-infected patients. AIDS 1996, 10:619-623.
18. Orenstein JM, Dieterich DT, Lew AE, Kotler D: Albendazole as a treatment for intestinal and disseminated microsporidiosis due to Septata intestinalis in AIDS patients: a report of four patients. AIDS 1993, 7 (suppl 3):S40-S42.
19. Molina JM, Oksenhendler E, Beauvais B, et al.: Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy. J Infect Dis 1995, 171:245-249.
20. Waller T: Sensitivity of Encephalitozoon cuniculi to various temperatures, disinfectants and drugs. Lab Animals 1979, 13:227-230.
21. Liu LX, Weller PE: Antiparasitic drugs. N Engl J Med 1996, 334:1178-1184.
22. McCowen MC, Callender ME, Lawlis Jr JF: Fumagillin (H-3), a new antibiotic with amebicidal properties. Science 1951, 113:202-203.
23. Killough JH, Magill GB, Smith RC: The treatment of amebiasis with fumagillin. Science 1952, 115:71-72.
24. McHardy G, Frye WW: Antibiotics in the management of amebiasis. JAMA 1954, 8:646-651.
25. Shadduck k JA: Effect of fumagillin on in vitro multiplication of Encephalitozoon cuniculi. J Protozool 1980, 27:202-208.
26. Jaronski ST: Cytochemical evidence for RNA synthesis inhibition by fumagillin. J Antibiot 1972, 25:327-331.
27. Yee RW, Tio FO, Martinez JA, et al.: Resolution of microsporidial epithelial keratopathy in a patient with AIDS. Ophthalmology 1991, 98:196-201.
28. Diesenhouse MC, Wilson LA, Corrent GF, et al.: Treatment of microsporidial keratoconjunctivitis with topical fumagillin. Am J Ophthalmol 1993, 115:293-298.
29. Rosberger DF, Serdarevic ON, Erlandson RA, et al.: Successful treatment of microsporidial keratoconjunctivitis with topical fumagillin in a patient with AIDS. Cornea 1993, 12:261-265.
30. Wilkins JH, Joshi N, Margolis TP, Cevallos V, Dawson CR: Microsporidial keratoconjunctivitis treated successfully with a short course of fumagillin. Eye 1994, 8:703-704.
31. Dipaolo JA, Tarbell DS, Moore GE: Studies on the carcinolytic activity of fumagillin and some of its derivatives. Antibiot Annu 1958-1959:541-546.
32. Ingber D, Fujita T, Kishimoto S, et al.: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 1990, 348:555-557.
33. Goguel J, Katlama C, Sarfati C, Maslo C, Leport C, Molina JM: Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy [letter]. AIDS 1997, 11:1603-1610.